Related Experiment Video
Updated: Aug 15, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Post-infectious encephalomyelitis
1SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA. mihaic@upstate.edu.
Abstract:
The term post-infectious encephalomyelitis (PIEM) is frequently used interchangeably with acute disseminated encephalomyelitis (ADEM), although technically PIEM occurs after a known infection whereas with ADEM there is no antecedent infection. PIEM represents one of the primary demyelinating disorders of the central nervous system, along with multiple sclerosis and Devic's disease. There is no specific diagnostic test for any of these conditions and at onset it may be difficult to differentiate between ADEM and the first attack of multiple sclerosis. However, there are clinical and magnetic resonance imaging features that allow differentiation between PIEM/ADEM and a relapsing disease such as multiple sclerosis. Some patients improve spontaneously; most improve with methylprednisolone. If that fails, plasma exchange or intravenous immunoglobulin may be effective.
Insights
Post-infectious encephalomyelitis (PIEM) and acute disseminated encephalomyelitis (ADEM) are demyelinating central nervous system disorders. Clinical and MRI features help differentiate these from multiple sclerosis, with methylprednisolone often effective for treatment.
Area of Science:
- Neurology
- Immunology
- Neuroimmunology
Background:
- Post-infectious encephalomyelitis (PIEM) and acute disseminated encephalomyelitis (ADEM) are primary demyelinating disorders of the central nervous system.
- These conditions are often confused with multiple sclerosis (MS) and Devic's disease.
- Distinguishing between ADEM/PIEM and the initial presentation of MS can be challenging due to the lack of specific diagnostic tests.
Purpose of the Study:
- To clarify the distinction between PIEM and ADEM.
- To outline the diagnostic challenges in differentiating PIEM/ADEM from other demyelinating diseases.
- To discuss the therapeutic strategies for PIEM/ADEM.
Main Methods:
- Review of clinical and magnetic resonance imaging (MRI) features.
- Comparison of diagnostic criteria for ADEM, PIEM, and MS.
- Analysis of treatment outcomes for various therapeutic interventions.
Main Results:
- PIEM follows a known infection, while ADEM lacks a clear antecedent infection.
- Clinical and MRI findings can differentiate PIEM/ADEM from relapsing neurological diseases like MS.
- Methylprednisolone is a common and often effective treatment.
Conclusions:
- Accurate differentiation of PIEM/ADEM from other demyelinating disorders is crucial for appropriate management.
- While spontaneous recovery occurs, most patients benefit from treatments like methylprednisolone.
- Plasma exchange and intravenous immunoglobulin are effective alternatives when initial therapy fails.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Poliomyelitis
Viral Meningitis
Brain Abscess l: Introduction

